Months after Susan G. Komen for the Cure reversed its decision to stop funding cancer screenings at Planned Parenthood after facing an avalanche of criticism, Komen founder Nancy Brinker is stepping down as CEO at the end of the month. She will remain at the organization in a new management role focusing on strategy and fundraising. Liz Thompson, the charity’s president, also will leave in September, reportedly because of concerns about Brinker’s continuing influence at Komen. According to the Washington Post, a Komen spokeswoman said Thompson “had been considering leaving for several months. She had accomplished what she wanted to do and it was time to move on.” Two Komen board members will leave the charity’s board of the directors at the same time.